Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-β-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain)
- 6 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (10), 1253-1258
- https://doi.org/10.1007/s10096-009-0765-x
Abstract
The purpose of this paper was to investigate the occurrence of carbapenem-resistant Enterobacter cloacae in our institution, to detect the carbapenemase-associated resistance and to determine the genetic relatedness of the isolates. Species identification and antimicrobial susceptibility testing were performed using the Vitek 2 system and Etest. Multiplex polymerase chain reaction–enzyme linked immunosorbent assay (PCR-ELISA) was used for the detection of extended-spectrum β-lactamase (ESBL)-producers. The bla IMP and bla VIM genes were amplified by PCR and sequenced. The DiversiLab System was used for strain-typing. During the period 2006–2008, 12 different isolates of carbapenem-resistant E. cloacae (2.3 %) were recovered in our laboratory. Only two positive isolates for the bla VIM gene were detected. The minimum inhibitory concentration (MIC) values were higher for all carbapenems in the group of non-metallo-β-lactamase (MBL)-producers. All isolates showed MIC values ≤2 against this tigecycline. The two bla VIM-1-carrying isolates showed different genotypes. For non-MBL-producers, two clonally related clusters were observed. Different mechanisms can be associated with carbapenem-resistance in E. cloacae. MBL-producing strains are less prevalent than those with other mechanisms of resistance. The clonal relationship confirms the risk of spread of these organisms with the transfer of patients to different wards and the persistence of these clones over time or the ‘de novo’ acquisition of the resistance caused by the selective pressure exerted by antibiotics treatments.Keywords
This publication has 29 references indexed in Scilit:
- Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in GreeceJournal of Antimicrobial Chemotherapy, 2007
- Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)Microbial Drug Resistance, 2006
- In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek HospitalsAntimicrobial Agents and Chemotherapy, 2006
- Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase geneClinical Microbiology & Infection, 2006
- First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospitalJournal of Antimicrobial Chemotherapy, 2005
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Specificity of enterobacterial repetitive intergenic consensus and repetitive extragenic palindromic polymerase chain reaction for the detection of clonality within the Enterobacter cloacae complexDiagnostic Microbiology and Infectious Disease, 2005
- Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemasesDiagnostic Microbiology and Infectious Disease, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Spread of blaVIM-1-producing e. coli in a university hospital in Greece. Genetic analysis of the integron carrying the blaVIM-1 metallo-β-lactamase geneDiagnostic Microbiology and Infectious Disease, 2004